反応式
NCCCNCCCCNCCCN.[C@@H:15]1([O:46]P(O)(O)=O)[C@@H:20]([O:21]P(O)(O)=O)[C@H:19]([O:26]P(O)(O)=O)[C@@H:18]([O:31]P(O)(O)=O)[C@@H:17]([O:36]P(O)(O)=O)[C@H:16]1[O:41]P(O)(O)=O>>[O:21]=[CH:20][C@@H:19]([C@H:18]([C@@H:17]([C@@H:16]([CH2:15][OH:46])[OH:41])[OH:36])[OH:31])[OH:26]参加物
3
実験手順
A composition contemplated by the instant invention was prepared by dissolving human insulin with spermine and phytic acid in double distilled water (“DDW”) containing NaOH. The solution was then lyophilized and suspended with sodium dodecanoate (SD), octanol and geraniol in a mixture of mineral oil, medium chain triglyceride (MCT) oil and castor oil. Components and concentrations are detailed in Table 1.
後処理
- customwas prepared
- distillationin double distilled water (“DDW”)
- additioncontaining NaOH
- additionsuspended with sodium dodecanoate (SD), octanol and geraniol in a mixture of mineral oil, medium chain triglyceride (MCT) oil and castor oil
- concentrationComponents and concentrations
出典と根拠
- ORDレコード
- ord-d34855ce44584ab087d42f08dc818a1c
- 出典データセット
- uspto-grants-2012_08
- 特許番号
- US08241670B2
関連ノート
読み込み中…